INSULIN, CORTISOL AND CATECHOLAMINES DO NOT REGULATE CIRCADIAN VARIATIONS IN FIBRINOLYTIC-ACTIVITY

被引:32
作者
CHANDLER, WL
MORNIN, D
WHITTEN, RO
ANGLETON, P
FARIN, FM
FRITSCHE, TR
VEITH, RC
STRATTON, JR
机构
[1] UNIV WASHINGTON,DEPT MED,SEATTLE,WA 98195
[2] UNIV WASHINGTON,CTR EDUC & CLIN,DEPT GERIAT RES,SEATTLE,WA 98195
[3] UNIV WASHINGTON,DEPT PSYCHIAT & BEHAV SCI,SEATTLE,WA 98195
[4] VET ADM MED CTR,SEATTLE,WA 98108
关键词
catecholamine; circadian rhythm; cortisol; fibrinolysis; insulin;
D O I
10.1016/0049-3848(90)90238-8
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
To evaluate possible hormonal regulators of the diurnal rhythm in fibrinolytic activity, we measured tissue plasminogen activator (t-PA) activity, plasminogen activator inhibitor activity (PAI-1), t-PA antigen, insulin, cortisol, and catecholamines in 6 healthy males (age 34±5) every 2 hours for 24 hours. Fibrinolysis was characterized by a peak in PAI-1 activity and a trough in t-PA activity at 0600 h. PAI-1 activity increased 92% and t-PA activity decreased 56% between 2400 h and 0600 h. t-PA antigen (principally a measure of t-PA/PAI-1 complex), peaked at 0800 h. In comparison, insulin levels were lowest at night when PAI-1 activity was rising. The weak inverse correlation between insulin and PAI-1 activity (r = -0.28, p < 0.02), was not sufficient to explain the diurnal change in fibrinolysis. While cortisol demonstrated the expected circadian change, the increase in cortisol did not occur until 0400 h, 4-6 hours after the rise in PAI-1 and decrease in t-PA activity started. Supine resting plasma epinephrine and norepinephrine showed no circadian rhythm. From this data, we hypothesize that the increased level of PAI-1 in the morning consumes t-PA, leading to decreased t-PA activity and increased t-PA/PAI-1 complex. Further, we conclude that insulin, cortisol, and catecholamines are not responsible for the circadian rhythm of fibrinolysis. © 1990.
引用
收藏
页码:1 / 12
页数:12
相关论文
共 28 条
[1]  
AILLAUD MF, 1985, THROMB HAEMOSTASIS, V54, P466
[2]  
ALESSI MC, 1988, THROMB HAEMOSTASIS, V60, P491
[3]  
ANDREOTTI F, 1988, Fibrinolysis, V2, P90
[4]   DIURNAL-VARIATION OF TISSUE-TYPE PLASMINOGEN-ACTIVATOR AND ITS RAPID INHIBITOR (PAI-1) [J].
ANGLETON, P ;
CHANDLER, WL ;
SCHMER, G .
CIRCULATION, 1989, 79 (01) :101-106
[5]  
BREUER H, 1976, METHODS HORMONE ANAL
[6]  
CHANDLER WL, 1989, CLIN CHEM, V35, P787
[7]  
CHANDLER WL, 1989, J LAB CLIN MED, V113, P362
[8]  
EVANS MI, 1978, CLIN CHEM, V24, P567
[9]  
FRIBERGER P, 1982, SCAND J CLIN LA S162, V42, P49
[10]  
GADER A M A, 1973, Thrombosis Research, V2, P9, DOI 10.1016/0049-3848(73)90075-3